Options
Groves, Peter J
- PublicationCan a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity?(Elsevier Ltd, 2021)
; ;Williamson, Sarah L; ;Diamond, Madeline ;Melanie Ngo ;Han, AnitaSharpe, Sue MDay old layer chicks were challenged with Salmonella Typhimurium using a seeder bird technique. Treatment groups were untreated control, administration of a probiotic in drinking water weekly, vaccination by intramuscular injection of a live aro-A deletion mutant vaccine at 10 weeks of age (woa) followed by an oral dose at 16 woa, probiotic administration plus vaccination, vaccination plus the administration of an organic acid preparation in feed from 16 woa and a combination of probiotic, vaccine and organic acid. Faecal shedding was monitored by culture at 1, 2, 3, 4, 8, 12, 15, 17, 20, 21, 23 and 25 woa and in dust from settle plates by PCR at intervals from 8 woa. Birds from each group were separated at 17 and 18 woa and challenged orally with 106 CFU of S. Typhimurium. Both untreated and probiotic groups shed Salmonella until 56 days. Salmonella was also detected in dust from 8 until 12 woa but little after this. After vaccination, from sexual maturity (18 woa) all groups except those that were vaccinated with and without probiotic re-excreted Salmonella. The probiotic alone was ineffective against this re-excretion and all groups receiving organic acids shed Salmonella. At 17 woa, unchallenged controls were fully susceptible to caecal colonization, however all other groups showed reduced susceptibility, including the untreated challenged group. However, at 18 woa (sexual maturity) only the groups that were vaccinated with or without probiotic showed reduced susceptibility to colonization. The organic acid treated groups (including the vaccinated group) did not show a difference to the untreated controls. S. Typhimurium demonstrated an ability to re-emerge at sexual maturity, similar to other serovars. The vaccine assisted in limiting the reexcretion at sexual maturity and decreased susceptibility to subsequent challenge. Use of a probiotic augmented the vaccine’s protective capacity.